|
|
NOL7 |
nucleolar protein 7 |
|
|
|
|
|
NOLC1 |
nucleolar and coiled-body phosphoprotein 1 |
|
|
|
|
|
NOP16 |
NOP16 nucleolar protein |
|
|
|
|
|
NOS1AP |
nitric oxide synthase 1 adaptor protein |
|
|
|
|
|
NOS3 |
nitric oxide synthase 3 |
- ROS and RNS production in phagocytes
- Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
- eNOS activation
- eNOS activation
- NOSTRIN mediated eNOS trafficking
- NOSIP mediated eNOS trafficking
- Nitric oxide stimulates guanylate cyclase
- VEGFR2 mediated vascular permeability
- Extra-nuclear estrogen signaling
- High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
|
- Arginine
- Citrulline
- Sapropterin
- Nitric Oxide
- Miconazole
- N,N-dimethylarginine
- L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide
- Canavanine
- 3-Bromo-7-Nitroindazole
- N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine
- N-[3-(aminomethyl)benzyl]acetamidine
- 1,2,4-Triazole-Carboxamidine
- L-N(omega)-nitroarginine-(4R)-amino-L-proline amide
- S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea
- 7-Nitroindazole
- S-Ethylisothiourea
- 2-Aminothiazoline
- Se-Ethyl-Isoselenourea
- 2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine
- N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane
- Cacodylic acid
- 7-Nitroindazole-2-Carboxamidine
- 6-Nitroindazole
- N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine
- N(G)-Iminoethylornithine
- 5,6-Cyclic-Tetrahydropteridine
- S-Ethyl-N-Phenyl-Isothiourea
- S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea
- 6S-5,6,7,8-Tetrahydrobiopterin
- S-(Dimethylarsenic)Cysteine
- L-homoarginine
- S-Isopropyl-Isothiourea
- Nitroarginine
- 5-Nitroindazole
- N-(Chlorophenyl)-N'-hydroxyguanidine
- (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine
- 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE
- ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
- N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE
- N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine
- Levamlodipine
|
|
|
|
NOVA1 |
NOVA alternative splicing regulator 1 |
|
|
|
|
|
NPL |
N-acetylneuraminate pyruvate lyase |
|
|
|
|
|
NPM1 |
nucleophosmin 1 |
- Nuclear import of Rev protein
- Nuclear import of Rev protein
- SUMOylation of transcription cofactors
- Deposition of new CENPA-containing nucleosomes at the centromere
- TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
- TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
- SARS-CoV-1-host interactions
- ALK mutants bind TKIs
- Signaling by ALK fusions and activated point mutants
- Nuclear events stimulated by ALK signaling in cancer
- PKR-mediated signaling
|
|
|
|
|
NR1D1 |
nuclear receptor subfamily 1 group D member 1 |
- PPARA activates gene expression
- Transcriptional activation of mitochondrial biogenesis
- Nuclear Receptor transcription pathway
- Heme signaling
- Heme signaling
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
|
|
|
|
|
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
- PPARA activates gene expression
- VLDLR internalisation and degradation
- NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake
- NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
- NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
- NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
|
- TO-901317
- N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE
- 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
- (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID
- Diacerein
- Rhein
|
|
|
|
NRIP1 |
nuclear receptor interacting protein 1 |
- SUMOylation of transcription cofactors
- Estrogen-dependent gene expression
- NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
- NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
- Heme signaling
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
|
- 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE
|
|
|
|
NSD2 |
nuclear receptor binding SET domain protein 2 |
- PKMTs methylate histone lysines
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Nonhomologous End-Joining (NHEJ)
- Processing of DNA double-strand break ends
- G2/M DNA damage checkpoint
|
|
|
|
|
NSRP1 |
nuclear speckle splicing regulatory protein 1 |
- mRNA Splicing - Major Pathway
|
|
|
|
|
NTM |
neurotrimin |
- Post-translational modification: synthesis of GPI-anchored proteins
|
|
|
|
|
NTMT1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
|
|
|
|
|
NTRK3 |
neurotrophic receptor tyrosine kinase 3 |
- PIP3 activates AKT signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- Receptor-type tyrosine-protein phosphatases
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- NTF3 activates NTRK3 signaling
- NTF3 activates NTRK3 signaling
- Signaling by NTRK3 (TRKC)
- Activated NTRK3 signals through PLCG1
- Activated NTRK3 signals through PLCG1
- Activated NTRK3 signals through RAS
- Activated NTRK3 signals through PI3K
- Activated NTRK3 signals through PI3K
- NTRK3 as a dependence receptor
|
- Entrectinib
- Fostamatinib
- Larotrectinib
- Pralsetinib
|
|
|
|
NUAK1 |
NUAK family kinase 1 |
- Regulation of TP53 Activity through Phosphorylation
|
|
|
|
|
NUAK2 |
NUAK family kinase 2 |
|
|
|
|
|
NUDT16L1 |
nudix hydrolase 16 like 1 |
|
|
|
|
|
NUDT16L2P |
nudix hydrolase 16 like 2, pseudogene |
|
|
|